Multichannel Marketing in Healthcare: Industry Perspectives. This free report is intended to support understanding of how multichannel marketing is evolving within the healthcare industry, including trends, advances and obstacles.
In an experimental study, psychologist Victoria Shaffer compared the ratings patients give to physicians who didn’t ask for advice, physicians who asked another expert for advice, and physicians who used decision-making software for treatment advice.
“Patients had no problem with [physicians who seek] consulting advice from an expert,” Shaffer said. “It was really the use of the computerized decision aid that makes them most concerned.”
Les acteurs du secteur de la santé ne sont pas indifférents aux risques que fait encourir l’automédication et l’autodiagnostic. Tandis que les pouvoirs publics organisent le filtrage qualitatif des informations, les médecins et les laboratoires privilégient une démarche éducative.
Time to step up or step out of the way? The digital health movement is growing rapidly. Almost everyday we hear of new technology, apps and ideas that bring the promise of improved medical care, health and wellness.
Medikly, a leading cloud-based, intelligent digital platform, today announced that Mark Goldstone joins the company as Co-CEO, along with current CEO and Founder, Venkat Gullapalli, MD. The announcement follows Medikly's recent multi-million dollar Series A funding, further solidifying the company's commitment to helping pharmaceutical companies better reach, engage and understand physicians. Together Goldstone and Gullapalli will advance the company's Software-as-a-Service (SaaS) platform, which continues to see exceptional growth and demand among pharmaceutical brands and marketing agencies.
Goldstone, who was most recently President of DDB's worldwide healthcare business, brings a wealth of.....
The U.K.'s struggling AstraZeneca ($AZN) is not only looking to media that is social to develop some kind of relationship with patients; it has gone local as well.
The company provided some resources as well as expertise for the My Medication Passport tracker, which was funded by the National Institute for Health Research (NIHR) for use across the National Health System (NHS) in the U.K., according to PMLive. The tool can be used as an Android or iPhone app and also comes in a paper booklet for those who prefer the traditional form of documentation.
It allows patients or their caregivers to track some of the usual kinds of health data, like which drugs are to be taken in what doses and when. It also includes information on sensitivities, allergies and vaccinations, as well as some hospitals and other information. It was provided to more than 5,000 patients across Imperial College Healthcare NHS Trust as it was being developed and is now being distributed more widely in the country, PMLive reported.
Check out http://wirelesshealthstrategies.com! The digital revolution is catalyzing a profound transformation and creative disruption of the methods by which healthcare providers deliver patient care, patients access healthcare services and...
Le 4 avril 2012, les pharmaciens décrochaient pour la première fois de leur histoire une rémunération forfaitisée pour le suivi des patients sous AVK. Une décision historique, inscrite dans le marbre d'un avenant conventionnel. Les infirmières pourraient-elles prétendre à bénéficier d'un même dispositif?
E-details soar as pharmas slash sales forces Medical Marketing and Media That said, such a rise in one media channel could also signal a rise of digital budgets overall as marketers and pharma companies alike continue to employ a more holistic...
Since 2005, we developed and implemented a strategy to create a new pharma market approach in the Netherlands. Since 2010 it proves to be effective to grow ROI. Here (1/2) we describe concisely the project. In a few days, we will present a chalkboard sketch of the approach (2/2), based upon our review of the very project and our activities to change the market approach and make it all effective. It hasn’t been a very structured process, as experimentation and development often is not, but the innovation worked and we could collect its benefits to the ROI of our client, a local affiliate of a large global pharmaceutical company. We are now using the decision and action tools that we developed in the course of the project, to create more adaptive pharma roles for other companies as well.